Covetrus Inc (CVET) Fundamental Analysis & Valuation

NASDAQ:CVET • US22304C1009

Current stock price

20.99 USD
+0.06 (+0.29%)
At close:
20.99 USD
0 (0%)
After Hours:

This CVET fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. CVET Profitability Analysis

1.1 Basic Checks

  • CVET had positive earnings in the past year.
  • In the past year CVET had a positive cash flow from operations.
CVET Yearly Net Income VS EBIT VS OCF VS FCFCVET Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 0 -200M -400M -600M -800M

1.2 Ratios

Industry RankSector Rank
ROA -0.38%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CVET Yearly ROA, ROE, ROICCVET Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 0 -20 -40 -60

1.3 Margins

Industry RankSector Rank
OM -0.02%
PM (TTM) -0.28%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CVET Yearly Profit, Operating, Gross MarginsCVET Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 0 10 -10 -20

2

2. CVET Health Analysis

2.1 Basic Checks

  • CVET does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for CVET has been increased compared to 1 year ago.
  • Compared to 1 year ago, CVET has a worse debt to assets ratio.
CVET Yearly Shares OutstandingCVET Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 20M 40M 60M 80M 100M
CVET Yearly Total Debt VS Total AssetsCVET Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 1B 2B 3B

2.2 Solvency

  • CVET has an Altman-Z score of 2.08. This is not the best score and indicates that CVET is in the grey zone with still only limited risk for bankruptcy at the moment.
  • CVET has a debt to FCF ratio of 524.50. This is a negative value and a sign of low solvency as CVET would need 524.50 years to pay back of all of its debts.
  • A Debt/Equity ratio of 0.65 indicates that CVET is somewhat dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF 524.5
Altman-Z 2.08
ROIC/WACCN/A
WACC7.62%
CVET Yearly LT Debt VS Equity VS FCFCVET Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 0 500M 1B 1.5B

2.3 Liquidity

  • CVET has a Current Ratio of 1.88. This is a normal value and indicates that CVET is financially healthy and should not expect problems in meeting its short term obligations.
  • A Quick Ratio of 1.08 indicates that CVET should not have too much problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 1.88
Quick Ratio 1.08
CVET Yearly Current Assets VS Current LiabilitesCVET Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 500M 1B

5

3. CVET Growth Analysis

3.1 Past

  • CVET shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 4.89%.
  • The Earnings Per Share has been growing by 25.19% on average over the past years. This is a very strong growth
  • The Revenue has been growing slightly by 2.42% in the past year.
  • CVET shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.41% yearly.
EPS 1Y (TTM)4.89%
EPS 3Y25.19%
EPS 5YN/A
EPS Q2Q%-3.85%
Revenue 1Y (TTM)2.42%
Revenue growth 3Y6.59%
Revenue growth 5Y6.41%
Sales Q2Q%2.35%

3.2 Future

  • Based on estimates for the next years, CVET will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.74% on average per year.
  • Based on estimates for the next years, CVET will show a small growth in Revenue. The Revenue will grow by 5.42% on average per year.
EPS Next Y16.83%
EPS Next 2Y16.41%
EPS Next 3Y13.76%
EPS Next 5Y12.74%
Revenue Next Year4.28%
Revenue Next 2Y5.17%
Revenue Next 3Y5.57%
Revenue Next 5Y5.42%

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
CVET Yearly Revenue VS EstimatesCVET Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2B 4B 6B
CVET Yearly EPS VS EstimatesCVET Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5

2

4. CVET Valuation Analysis

4.1 Price/Earnings Ratio

  • CVET is valuated rather expensively with a Price/Earnings ratio of 21.20.
  • Compared to an average S&P500 Price/Earnings ratio of 26.78, CVET is valued a bit cheaper.
  • A Price/Forward Earnings ratio of 16.20 indicates a correct valuation of CVET.
  • The average S&P500 Price/Forward Earnings ratio is at 23.54. CVET is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 21.2
Fwd PE 16.2
CVET Price Earnings VS Forward Price EarningsCVET Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF 1470.59
EV/EBITDA 23.66
CVET Per share dataCVET EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

  • CVET's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • CVET's earnings are expected to grow with 13.76% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.26
PEG (5Y)N/A
EPS Next 2Y16.41%
EPS Next 3Y13.76%

0

5. CVET Dividend Analysis

5.1 Amount

  • CVET does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CVET Fundamentals: All Metrics, Ratios and Statistics

Covetrus Inc

NASDAQ:CVET (10/12/2022, 8:10:14 PM)

After market: 20.99 0 (0%)

20.99

+0.06 (+0.29%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)08-04
Earnings (Next)11-03
Inst Owners0%
Inst Owner Change0%
Ins Owners2.47%
Ins Owner Change0%
Market Cap2.94B
Revenue(TTM)4.65B
Net Income(TTM)-13.00M
Analysts50.91
Price Target21.76 (3.67%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)3.3%
Min EPS beat(2)-3.06%
Max EPS beat(2)9.66%
EPS beat(4)2
Avg EPS beat(4)1.75%
Min EPS beat(4)-3.06%
Max EPS beat(4)9.66%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.74%
Min Revenue beat(2)-2.09%
Max Revenue beat(2)-1.39%
Revenue beat(4)0
Avg Revenue beat(4)-2.2%
Min Revenue beat(4)-3.13%
Max Revenue beat(4)-1.39%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 21.2
Fwd PE 16.2
P/S 0.63
P/FCF 1470.59
P/OCF 45.96
P/B 1.95
P/tB N/A
EV/EBITDA 23.66
EPS(TTM)0.99
EY4.72%
EPS(NY)1.3
Fwd EY6.17%
FCF(TTM)0.01
FCFY0.07%
OCF(TTM)0.46
OCFY2.18%
SpS33.18
BVpS10.74
TBVpS-1.02
PEG (NY)1.26
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -0.38%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -0.02%
PM (TTM) -0.28%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover1.37
Health
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF 524.5
Debt/EBITDA N/A
Cap/Depr 37.35%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality -15.38%
Current Ratio 1.88
Quick Ratio 1.08
Altman-Z 2.08
F-Score6
WACC7.62%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)4.89%
EPS 3Y25.19%
EPS 5YN/A
EPS Q2Q%-3.85%
EPS Next Y16.83%
EPS Next 2Y16.41%
EPS Next 3Y13.76%
EPS Next 5Y12.74%
Revenue 1Y (TTM)2.42%
Revenue growth 3Y6.59%
Revenue growth 5Y6.41%
Sales Q2Q%2.35%
Revenue Next Year4.28%
Revenue Next 2Y5.17%
Revenue Next 3Y5.57%
Revenue Next 5Y5.42%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-98.21%
FCF growth 3Y-32.39%
FCF growth 5Y-14.53%
OCF growth 1Y-58.44%
OCF growth 3Y-13.56%
OCF growth 5Y-0.54%

Covetrus Inc / CVET Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for Covetrus Inc?

ChartMill assigns a fundamental rating of 4 / 10 to CVET.


Can you provide the valuation status for Covetrus Inc?

ChartMill assigns a valuation rating of 3 / 10 to Covetrus Inc (CVET). This can be considered as Overvalued.


How profitable is Covetrus Inc (CVET) stock?

Covetrus Inc (CVET) has a profitability rating of 3 / 10.


What are the PE and PB ratios of Covetrus Inc (CVET) stock?

The Price/Earnings (PE) ratio for Covetrus Inc (CVET) is 21.2 and the Price/Book (PB) ratio is 1.95.


How sustainable is the dividend of Covetrus Inc (CVET) stock?

The dividend rating of Covetrus Inc (CVET) is 0 / 10 and the dividend payout ratio is 0%.